|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Slotman BJ, van Tinteren H, Praag JO,
Knegjens JL, El Sharouni SY, Hatton M, Keijser A, Faivre-Finn C and
Senan S: Use of thoracic radiotherapy for extensive stage
small-cell lung cancer: A phase 3 randomised controlled trial.
Lancet. 385:36–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zimmermann FB, Geinitz H, Schill S, Grosu
A, Schratzenstaller U, Molls M and Jeremic B: Stereotactic
hypofractionated radiation therapy for stage I non-small cell lung
cancer. Lung Cancer. 48:107–114. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marks LB, Bentzen SM, Deasy JO, Kong FM,
Bradley JD, Vogelius IS, El Naqa I, Hubbs JL, Lebesque JV,
Timmerman RD, et al: Radiation dose-volume effects in the lung. Int
J Radiat Oncol Biol Phys. 76 3 Suppl:S70–S76. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vogelius IR and Bentzen SM: A
literature-based meta-analysis of clinical risk factors for
development of radiation induced pneumonitis. Acta Oncol.
51:975–983. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Onishi H, Shirato H, Nagata Y, Hiraoka M,
Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, et al:
Stereotactic body radiotherapy (SBRT) for operable stage I
non-small-cell lung cancer: Can SBRT be comparable to surgery? Int
J Radiat Oncol Biol Phys. 81:1352–1358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Timmerman RD and Kavanagh BD: Stereotactic
body radiation therapy. Curr Probl Cancer. 29:120–157. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Timmerman R, Paulus R, Galvin J, Michalski
J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone
D, et al: Stereotactic body radiation therapy for inoperable early
stage lung cancer. JAMA. 303:1070–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Albain KS, Swann RS, Rusch VW, Turrisi AT
III, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara
DR, et al: Radiotherapy plus chemotherapy with or without surgical
resection for stage III non-small-cell lung cancer: A phase III
randomised controlled trial. Lancet. 374:379–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bradley JD, Hope A, El Naqa I, Apte A,
Lindsay PE, Bosch W, Matthews J, Sause W, Graham MV and Deasy JO:
RTOG: A nomogram to predict radiation pneumonitis, derived from a
combined analysis of RTOG 9311 and institutional data. Int J Radiat
Oncol Biol Phys. 69:985–992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu GD, Xia L, Zhu JW, Ou S, Li MX, He Y,
Luo W, Li J, Zhou Q, Yang XQ, et al: Genistein alleviates
radiation-induced pneumonitis by depressing Ape-1/Ref-1 expression
to down-regulate inflammatory cytokines. Cell Biochem Biophys.
69:725–733. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Darby SC, McGale P, Taylor CW and Peto R:
Long-term mortality from heart disease and lung cancer after
radiotherapy for early breast cancer: Prospective cohort study of
about 300,000 women in US SEER cancer registries. Lancet Oncol.
6:557–565. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Henson KE, McGale P, Taylor C and Darby
SC: Radiation-related mortality from heart disease and lung cancer
more than 20 years after radiotherapy for breast cancer. Br J
Cancer. 108:179–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harkenrider MM, Bertke MH, Dunlap NE and
Dragun AE: Stereotactic body radiotherapy (SBRT) for
non-pathologically diagnosed lung cancer patients. J Solid Tumors.
2:2012. View Article : Google Scholar
|
|
16
|
Tucker SL, Liu HH, Liao Z, Wei X, Wang S,
Jin H, Komaki R, Martel MK and Mohan R: Analysis of radiation
pneumonitis risk using a generalized Lyman model. Int J Radiat
Oncol Biol Phys. 72:568–574. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oh D, Ahn YC, Park HC, Lim DH and Han Y:
Prediction of radiation pneumonitis following high-dose thoracic
radiation therapy by 3 Gy/fraction for non-small cell lung cancer:
Analysis of clinical and dosimetric factors. Jpn J Clin Oncol.
39:151–157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Holly TA, Abbott BG, Al-Mallah M, Calnon
DA, Cohen MC, DiFilippo FP, Ficaro EP, Freeman MR, Hendel RC, Jain
D, et al: Single photon-emission computed tomography. J Nucl
Cardiol. 17:941–973. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Muehllehner G and Karp JS: Positron
emission tomography. Phys Med Biol. 51:R117–R137. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scott CB, Nelson JS, Farnan NC, Curran WJ
Jr, Murray KJ, Fischbach AJ, Gaspar LE and Nelson DF: Central
pathology review in clinical trials for patients with malignant
glioma. A Report of Radiation Therapy Oncology Group 83-02. Cancer.
76:307–313. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Crabtree TD, Denlinger CE, Meyers BF, El
Naqa I, Zoole J, Krupnick AS, Kreisel D, Patterson GA and Bradley
JD: Stereotactic body radiation therapy versus surgical resection
for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg.
140:377–386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mehta V: Radiation pneumonitis and
pulmonary fibrosis in non-small-cell lung cancer: Pulmonary
function, prediction, and prevention. Int J Radiat Oncol Biol Phys.
63:5–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sura S, Gupta V, Yorke E, Jackson A, Amols
H and Rosenzweig KE: Intensity-modulated radiation therapy (IMRT)
for inoperable non-small cell lung cancer: The Memorial
Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol.
87:17–23. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang S, Liao Z, Wei X, Liu HH, Tucker SL,
Hu CS, Mohan R, Cox JD and Komaki R: Analysis of clinical and
dosimetric factors associated with treatment-related pneumonitis
(TRP) in patients with non-small-cell lung cancer (NSCLC) treated
with concurrent chemotherapy and three-dimensional conformal
radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 66:1399–1407.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Claude L, Pérol D, Ginestet C, Falchero L,
Arpin D, Vincent M, Martel I, Hominal S, Cordier JF and Carrie C: A
prospective study on radiation pneumonitis following conformal
radiation therapy in non-small-cell lung cancer: Clinical and
dosimetric factors analysis. Radiother Oncol. 71:175–181. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tell G, Damante G, Caldwell D and Kelley
MR: The intracellular localization of APE-1/Ref-1: More than a
passive phenomenon? Antioxid Redox Signal. 7:367–384. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Angkeow P, Deshpande SS, Qi B, Liu YX,
Park YC, Jeon BH, Ozaki M and Irani K: Redox factor-1: An
extra-nuclear role in the regulation of endothelial oxidative
stress and apoptosis. Cell Death Differ. 9:717–725. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Linard C, Marquette C, Mathieu J,
Pennequin A, Clarençon D and Mathé D: Acute induction of
inflammatory cytokine expression after gamma-irradiation in the
rat: Effect of an NF-kappaB inhibitor. Int J Radiat Oncol Biol
Phys. 58:427–434. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haase MG, Klawitter A, Geyer P, Alheit H,
Baumann M, Kriegel TM, Kasper M and Baretton GB: Sustained
elevation of NF-kappaB DNA binding activity in radiation-induced
lung damage in rats. Int J Radiat Biol. 79:863–877. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ando K, Hirao S, Kabe Y, Ogura Y, Sato I,
Yamaguchi Y, Wada T and Handa H: A new APE-1/Ref-1-dependent
pathway leading to reduction of NF-kappaB and AP-1, and activation
of their DNA-binding activity. Nucleic Acids Res. 36:4327–4336.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thakur S, Sarkar B, Cholia RP, Gautam N,
Dhiman M and Mantha AK: APE1/Ref-1 as an emerging therapeutic
target for various human diseases: Phytochemical modulation of its
functions. Exp Mol Med. 46:e1062014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tell G, Quadrifoglio F, Tiribelli C and
Kelley MR: The many functions of APE1/Ref-1: Not only a DNA repair
enzyme. Antioxid Redox Signal. 11:601–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koukourakis MI: Radiation damage and
radioprotectants: New concepts in the era of molecular medicine. Br
J Radiol. 85:313–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fox J and Haston CK: CXC receptor 1 and 2
and neutrophil elastase inhibitors alter radiation-induced lung
disease in the mouse. Int J Radiat Oncol Biol Phys. 85:215–222.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang LP, Wang YW, Wang BZ, Sun GM, Wang XY
and Xu JL: Expression of interleukin-17A in lung tissues of
irradiated mice and the influence of dexamethasone.
ScientificWorldJournal. 2014:2510672014.PubMed/NCBI
|
|
36
|
Wang BZ, Wang LP, Han H, Cao FL, Li GY, Xu
JL, Wang XW and Wang LX: Interleukin-17A antagonist attenuates
radiation-induced lung injuries in mice. Exp Lung Res. 40:77–85.
2014. View Article : Google Scholar : PubMed/NCBI
|
